Illustrative estimate only - not verified by this sponsor. Contact the study team for actual compensation.
Hypoglycemia can produce a spectrum of pro-inflammatory and pro-atherothrombotic changes. To date no studies appear to have investigated the effects of differing levels of hypoglycemia on the vasculature and pro-atherothrombotic balance during hypoglycemia in healthy man. The specific aim of our study will be to determine the effects of differing levels of hypoglycemia on in-vivo vascular biologic mechanisms in a healthy population.
What happens when you apply
Reach out via phone or email to express interest
Brief call to discuss your health history
Medical screening at the research site
Begin your journey in the study
Inclusion Criteria: • Body mass index \>21kg · m-2 Exclusion Criteria: * Pregnant women * Subjects unwilling or unable to comply with approved contraception measures * Subjects unable to give voluntary informed consent * Subjects on anticoagulant drugs, anemic or with known bleeding diatheses * Subjects with a history of severe, uncontrolled hypertension, heart disease, cerebrovascular incidents * Current tobacco use * Subjects with any known allergies to any of the study medications being used Physical Exam Exclusion Criteria * Uncontrolled severe hypertension (i.e., blood pressure greater than 160/100) * Clinically significant cardiac abnormalities (e.g. heart failure, arrhythmia) * Pneumonia treatment or hospitalization within 2 weeks prior to enrollment (study visit) * Hepatic failure / jaundice * Renal failure * Cerebrovascular accident occurrence or hospitalization within 4 weeks prior to enrollment * Fever greater than 38.0 degrees C Screening Laboratory Tests Exclusion Criteria * Hematocrit lower than 32 % * White blood cell (WBC) count lower than 3 thou/ul or greater than 14 thou/ul * Liver function tests: serum glutamic oxaloacetic transaminase (SGOT) and serum glutamic-pyruvic transaminase (SGPT) greater than twice upper limit of normal range * Alkaline phosphatase greater than 150U/L * Total bilirubin (TBil) greater than 2 mg/dl * Estimated glomerular filtration rate (eGFR) less than 60 mL/min/1.73 m2 * Positive human immunodeficiency virus (HIV), Hepatitis B or Hepatitis C * Any abnormal cardiac response during multi-stage exercise test (if over 40 years of age)
imaguineapig pulls live data from ClinicalTrials.gov (NIH/NLM).Illustrative estimate only - not verifiedPay estimates are approximate ranges based on study type and are not confirmed by sponsors — actual compensation may differ. Eligibility indicators use limited criteria (age, sex) only. We do not provide medical advice. Always contact the study team directly to confirm compensation, full eligibility, and risks before enrolling.